Loss of ONECUTI expression in human pancreatic cancer cells

Oncology Reports

Volumn 19, Issue 1, 2008, Pages 157-163

  Jiang, Xiaohua ^a,b   Zhang, Weiwei ^a   Kayed, Hany ^c   Zheng, Pan ^a   Giese, Nathalia A ^c   Friess, Helmut ^a   Kleeff, Jörg ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cilia; CYS1; Invasion; ONECUT1; Pancreatic cancer; PKHD1; TCF2

Indexed keywords

CYSTINE; FIBROCYSTIN; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 6; MESSENGER RNA; ONECUT1 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYS1 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONECUT1 PROTEIN, HUMAN; PKHD1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN;

ACINAR CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; CELL MOTION; DNA MICROARRAY; GENE EXPRESSION; IMMUNOBLOTTING; LASER; METABOLISM; MICRODISSECTION; PANCREAS CARCINOMA; PANCREAS TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 6; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LASERS; MEMBRANE PROTEINS; MICRODISSECTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 38749105025     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bisgrove BW and Yost HJ: The roles of cilia in developmental disorders and disease. Development 133: 4131-4143, 2006.
2. Oishi I, Kawakami Y, Raya A, Callol-Massot C and Izpisua Belmonte JC: Regulation of primary cilia formation and left-right patterning in zebrafish by a non-canonical Wnt signaling mediator, duboraya. Nat Genet 38: 1316-1322, 2006.
3. Davenport JR and Yoder BK: An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol 289: F1159-F1169, 2005.
4. Marshall WF and Nonaka S: Cilia: tuning in to the cell's antenna. Curr Biol 16: R604-R614, 2006.
5. Aughsteen AA: The ultrastructure of primary cilia in the endocrine and excretory duct cells of the pancreas of mice and rats. Eur J Morphol 39: 277-283, 2001.
6. Cano DA, Sekine S and Hebrok M: Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 131: 1856-1869, 2006.
7. Tahvanainen E, Tahvanainen P, Kaariainen H and Hockerstedt K: Polycystic liver and kidney diseases. Ann Med 37: 546-555, 2005.
8. Torres VE and Harris PC: Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2: 40-55, 2006.
9. Cano DA, Murcia NS, Pazour GJ and Hebrok M: Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization. Development 131: 3457-3467, 2004.
10. Pierreux CE, Poll AV, Kemp CR, Clotman F, Maestro MA, Cordi S, Ferrer J, Leyns L, Rousseau GG and Lemaigre FP: The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse. Gastroenterology 130: 532-541, 2006.
11. Kaestner KH: Of cilia and cysts: modeling pancreatic polycystic disease. Gastroenterology 130: 926-928, 2006.
12. Christensen ST, Pedersen LB, Schneider L and Satir P: Sensory cilia and integration of signal transduction in human health and disease. Traffic 8: 97-109, 2007.
13. Ibraghimov-Beskrovnaya O: Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy. Cell Cycle 6: 776-779, 2007.
14. Quarmby LM and Parker JD: Cilia and the cell cycle? J Cell Biol 169: 707-710, 2005.
15. Naitoh H, Shoji H, Ishikawa I, Watanabe R, Furuta Y, Tomozawa S, Igarashi H, Shinozaki S, Katsura H, Onozato R and Kudoh M: Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease. J Gastrointest Surg 9: 843-845, 2005.
16. Erkan M, Kleeff I, Esposito I, Giese T, Ketterer K, Buchler MW, Giese NA and Friess H: Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24: 4421-4432, 2005.
17. Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, Giese T, Penzel R, Zentgraf H, Buchler MW, Korc M and Friess H: FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 118: 43-54, 2006.
18. Ketterer K, Rao S, Friess H, Weiss J, Buchler MW and Korc M: Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 9: 5127-5136, 2003.
19. Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, Reidhaar-Olson JF, Korc M, Hammer J and Buchler MW: Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 60: 1180-1199, 2003.
20. Lannoy VJ, Burglin TR, Rousseau GG and Lemaigre FP: Isoforms of hepatocyte nuclear factor-6 differ in DNA-binding properties, contain a bifunctional homeodomain, and define the new ONECUT class of homeodomain proteins. J Biol Chem 273: 13552-13562, 1998.
21. Lemaigre FP, Durviaux SM, Truong O, Lannoy VJ, Hsuan JJ and Rousseau GG: Hepatocyte nuclear factor 6, a transcription factor that contains a novel type of homeodomain and a single cut domain. Proc Natl Acad Sci USA 93: 9460-9464, 1996.
22. Landry C, Clotman F, Hioki T, Oda H, Picard JJ, Lemaigre FP and Rousseau GG: HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Dev Biol 192: 247-257, 1997.
23. Rausa F, Samadani U, Ye H, Lim L, Fletcher CE, Jenkins NA, Copeland NG and Costa RH: The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas. Dev Biol 192: 228-246, 1997.
24. Poll AV, Pierreux CE, Lokmane L, Haumaitre C, Achouri Y, Jacquemin P, Rousseau GG, Cereghini S and Lemaigre FP: A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes 55: 61-69, 2006.
25. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI and Young RA: Control of pancreas and liver gene expression by HNF transcription factors. Science 303: 1378-1381, 2004.
26. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Eleishman DI, Engelhardt NV and Duncan SA: Progression of HCC in mice is associated with a down-regulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047, 2004.